Candel Therapeutics, Inc.
CADL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $87 | $101 | $92 | $103 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $3 | $1 | $1 |
| Total Curr. Assets | $90 | $104 | $93 | $104 |
| Property Plant & Equip (Net) | $3 | $2 | $2 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $2 | $3 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $94 | $106 | $96 | $107 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $1 | $0 |
| Short-Term Debt | $5 | $7 | $10 | $10 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $5 | $10 | $27 |
| Total Curr. Liab. | $11 | $15 | $20 | $38 |
| LT Debt | $2 | $1 | $1 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $0 | $0 | $0 |
| Total NC Liab. | $3 | $1 | $1 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $1 | $1 |
| Total Liabilities | $13 | $16 | $21 | $41 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $0 | $0 |
| Retained Earnings | -$201 | -$190 | -$185 | -$192 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $280 | $279 | $259 | $258 |
| Total Equity | $80 | $90 | $75 | $66 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $94 | $106 | $96 | $107 |
| Net Debt | -$81 | -$92 | -$81 | -$89 |